IPO SnapShot

PAR DRUGS AND CHEMICALS LTD.

IPODATE
May 03, 2019 TO May 08, 2019
LISTINGDATE
5/16/2019 12:00:00 AM
APPLY NOW
FACEVALUE
₹ 10

per share

ISSUESIZE
₹ 8.5272 Cr
PRICEBAND
₹ 51

per share

MARKETLOT
2000

shares

OBJECTIVE

1. Funding the working capital requirements of our Company and2. General corporate purposes.

DON'T HAVE A DEMAT ACCOUNT

OPENDEMAT ACCOUNTAND START YOURINVESTMENTJOURNEY WITH US

OPEN AN ACCOUNT (You will receive a call & SMS from our end)
BUSINESS DESCRIPTION

No Description found

ADDRESS

Address: 815
Nilamber Triumph
Gotri Vasna Road

City: Vadodara,
State: Gujarat
Pincode: 390007
Phone: 0265 2991021 / 2991022
Email: admin@pardrugs.com
Website: www.pardrugs.com

LISTED AT

NSE

LEAD MANAGER

Pantomath Capital Advisors Pvt Ltd.

PROMOTERS

Falgun Vallabhai Savani
Jignesh Vallabhai Savani

PROMOTER'S HOLDING

Total Share Capital

4460318

Offered to Public

1672000

Promoter's Holding (Pre-Issue)

99.55

Promoter's Holding (Post-Issue)

72.5
REGISTRAR

Link Intime India Pvt Ltd.
C 101
247 Park
LBS Marg
Vikhroli (West)
Mumbai

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.